JJJacob D. Jaffe
Jacob D. Jaffe
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jacob D. Jaffe has a total of 433 co-authors. Here are the top co-authors by number of shared publications:
- Malvina Papanastasiou
The Broad Institute of MIT and Harvard, Cambridge, United States of America
37 shared publications - Alanna L. Pyke
Stanford Department of Genetics
32 shared publications - Alex Toker
Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
32 shared publications - Alexander Meissner
Max Planck Institute for Molecular Genetics, Berlin, Germany
32 shared publications - Anne Fassl
German Cancer Research Center
32 shared publications - Anne Trinh
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
32 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S9 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S9 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figures from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States